Artal Group S.A.
- SEC CIK
- 0001053906
- Latest filing
- Aug 13, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 14, 2021. Long positions only.
- Positions
- 133
- No 13F data for Q4 2020
- Portfolio value
- $4.73B
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| WWWW International, Inc. | COM | 14,818,300 | $463.5M | 9.8% | – | – | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 71,178,364 | $417.8M | 8.8% | – | – | History |
| ONCBeOne Medicines Ltd. | ADR | 850,000 | $295.9M | 6.3% | – | – | History |
| SEERSeer, Inc. | COM CL A | 5,588,366 | $279.5M | 5.9% | – | – | History |
| XLRNAcceleron Pharma Inc | COM | 1,400,000 | $189.9M | 4.0% | – | – | History |
| RUBYRubius Therapeutics, Inc. | COM | 4,883,791 | $129.4M | 2.7% | – | – | History |
| MRTXMirati Therapeutics, Inc. | COM | 725,000 | $124.2M | 2.6% | – | – | History |
| ARGXArgenx SE | SPONSORED ADR | 450,000 | $123.9M | 2.6% | – | – | History |
| MORFMorphic Holding, Inc. | COM | 1,819,186 | $115.1M | 2.4% | – | – | History |
| FATEFate Therapeutics Inc | COM | 1,300,000 | $107.2M | 2.3% | – | – | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 750,000 | $105.9M | 2.2% | – | – | History |
| SRRKScholar Rock Holding Corp | COM | 2,000,000 | $101.3M | 2.1% | – | – | History |
| BNTXBioNTech SE | SPONSORED ADS | 900,000 | $98.3M | 2.1% | – | – | History |
| IGMSIGM Biosciences, Inc. | COM | 1,125,000 | $86.3M | 1.8% | – | – | History |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $80.1M | 1.7% | – | – | History |
| TGTXTG Therapeutics, Inc. | COM | 1,500,000 | $72.3M | 1.5% | – | – | History |
| SDGRSchrodinger, Inc. | COM | 797,445 | $60.8M | 1.3% | – | – | History |
| KLRSKalaris Therapeutics, Inc. | COM | 2,323,371 | $54.4M | 1.2% | – | – | History |
| INTCIntel Corp | Stock | 800,000 | $51.2M | 1.1% | – | – | History |
| SAGESage Therapeutics, Inc. | COM | 650,000 | $48.7M | 1.0% | – | – | History |
| IMAImageneBio, Inc. | COM | 1,549,513 | $43.8M | 0.9% | – | – | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $39.9M | 0.8% | – | – | History |
| ALXOAlx Oncology Holdings Inc | COM | 525,000 | $38.7M | 0.8% | – | – | History |
| KRONKronos Bio, Inc. | COM | 1,317,954 | $38.6M | 0.8% | – | – | History |
| KRYSKrystal Biotech, Inc. | COM | 500,000 | $38.5M | 0.8% | – | – | History |
| ChemoCentryx, Inc.16383L106 | COM | 750,000 | $38.4M | 0.8% | – | – | – |
| ITOSiTeos Therapeutics, Inc. | COM | 1,094,047 | $37.4M | 0.8% | – | – | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $37.3M | 0.8% | – | – | – |
| FOLDAmicus Therapeutics, Inc. | COM | 3,750,000 | $37.0M | 0.8% | – | – | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 750,000 | $36.4M | 0.8% | – | – | History |
| AVGOBroadcom Inc. | Stock | 75,000 | $34.8M | 0.7% | – | – | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 2,500,000 | $34.3M | 0.7% | – | – | History |
| BEKEKE Holdings Inc. | SPONSORED ADS | 600,000 | $34.2M | 0.7% | – | – | History |
| CARAvis Budget Group, Inc. | COM | 450,000 | $32.6M | 0.7% | – | – | History |
| TPTXTurning Point Therapeutics, Inc. | COM | 312,700 | $29.6M | 0.6% | – | – | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 400,000 | $29.4M | 0.6% | – | – | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 2,000,000 | $28.7M | 0.6% | – | – | History |
| DNLIDenali Therapeutics Inc. | COM | 500,000 | $28.6M | 0.6% | – | – | History |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,000,000 | $28.0M | 0.6% | – | – | History |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 2,500,000 | $26.9M | 0.6% | – | – | – |
| PRAXPraxis Precision Medicines, Inc. | COM | 750,000 | $24.6M | 0.5% | – | – | History |
| REPLReplimune Group, Inc. | COM | 800,000 | $24.4M | 0.5% | – | – | History |
| VORVor Biopharma Inc. | COM | 550,000 | $23.7M | 0.5% | – | – | History |
| ADVMAdverum Biotechnologies, Inc. | COM | 2,400,000 | $23.7M | 0.5% | – | – | History |
| NEXINexImmune, Inc. | COM | 1,200,000 | $22.9M | 0.5% | – | – | History |
| NGNovagold Resources Inc | COM NEW | 2,600,000 | $22.8M | 0.5% | – | – | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $22.7M | 0.5% | – | – | History |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $22.0M | 0.5% | – | – | History |
| GOSSGossamer Bio, Inc. | COM | 2,358,968 | $21.8M | 0.5% | – | – | History |
| ALBOAlbireo Pharma, Inc. | COM | 600,000 | $21.1M | 0.4% | – | – | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,040,882 | $21.1M | 0.4% | – | – | History |
| HARPHarpoon Therapeutics, Inc. | COM | 1,000,000 | $20.9M | 0.4% | – | – | History |
| DRNADicerna Pharmaceuticals Inc | COM | 800,000 | $20.5M | 0.4% | – | – | History |
| CRISCuris Inc | COM NEW | 1,804,729 | $20.4M | 0.4% | – | – | History |
| RNACCartesian Therapeutics, Inc. | COM | 4,500,000 | $20.4M | 0.4% | – | – | History |
| NTLAIntellia Therapeutics, Inc. | COM | 250,000 | $20.1M | 0.4% | – | – | History |
| CPNGCoupang, Inc. | CL A | 400,000 | $19.7M | 0.4% | – | – | History |
| MRSNMersana Therapeutics, Inc. | COM | 1,200,000 | $19.4M | 0.4% | – | – | History |
| APTXAptinyx Inc. | COM | 6,116,493 | $18.3M | 0.4% | – | – | History |
| Bellus Health Inc New07987C204 | COM NEW | 4,750,000 | $18.2M | 0.4% | – | – | – |
| IQiQIYI, Inc. | SPONSORED ADS | 1,025,000 | $17.0M | 0.4% | – | – | History |
| KURAKura Oncology, Inc. | COM | 600,000 | $17.0M | 0.4% | – | – | History |
| RPTXRepare Therapeutics Inc. | COM | 550,000 | $16.9M | 0.4% | – | – | History |
| TCRRTCR2 Therapeutics Inc. | COM | 750,000 | $16.6M | 0.4% | – | – | History |
| Translate Bio, Inc.89374L104 | COM | 1,000,000 | $16.5M | 0.3% | – | – | – |
| AGENAgenus Inc | COM NEW | 6,000,000 | $16.3M | 0.3% | – | – | History |
| BBIOBridgeBio Pharma, Inc. | COM | 250,000 | $15.4M | 0.3% | – | – | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $15.0M | 0.3% | – | – | History |
| ADAGAdagene Inc. | ADS | 800,000 | $14.4M | 0.3% | – | – | History |
| ZYMEZymeworks Inc. | COM | 450,000 | $14.2M | 0.3% | – | – | History |
| RLAYRelay Therapeutics, Inc. | COM | 400,000 | $13.8M | 0.3% | – | – | History |
| SANASana Biotechnology, Inc. | COM | 400,000 | $13.4M | 0.3% | – | – | History |
| YI111, Inc. | ADS | 966,349 | $13.3M | 0.3% | – | – | History |
| ORTXOrchard Therapeutics plc | ADS | 1,803,858 | $13.1M | 0.3% | – | – | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $13.0M | 0.3% | – | – | History |
| ZZillow Group, Inc. | CL C CAP STK | 100,000 | $13.0M | 0.3% | – | – | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 400,000 | $12.7M | 0.3% | – | – | History |
| SLDBSolid Biosciences Inc. | COM | 2,250,000 | $12.4M | 0.3% | – | – | History |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 800,000 | $12.4M | 0.3% | – | – | History |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $12.1M | 0.3% | – | – | History |
| DSGNDesign Therapeutics, Inc. | COM | 400,000 | $12.0M | 0.3% | – | – | History |
| TILInstil Bio, Inc. | COM | 450,000 | $11.3M | 0.2% | – | – | History |
| TMETencent Music Entertainment Group | SPON ADS | 550,000 | $11.3M | 0.2% | – | – | History |
| IMUXImmunic, Inc. | COM | 700,000 | $11.2M | 0.2% | – | – | History |
| EVLOEvelo Biosciences, Inc. | COM | 1,000,000 | $10.7M | 0.2% | – | – | History |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $10.1M | 0.2% | – | – | History |
| TCOMTrip.com Group Ltd | ADS | 250,000 | $9.91M | 0.2% | – | – | History |
| KYMRKymera Therapeutics, Inc. | COM | 250,000 | $9.71M | 0.2% | – | – | History |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $9.71M | 0.2% | – | – | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 200,000 | $8.97M | 0.2% | – | – | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 260,500 | $8.64M | 0.2% | – | – | History |
| ARAVAravive, Inc. | COM | 1,311,291 | $8.64M | 0.2% | – | – | History |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $8.51M | 0.2% | – | – | History |
| SYRESpyre Therapeutics, Inc. | COM | 1,045,000 | $8.28M | 0.2% | – | – | History |
| DYNDyne Therapeutics, Inc. | COM | 525,000 | $8.15M | 0.2% | – | – | History |
| GDSGDS Holdings Ltd | SPONSORED ADS | 100,000 | $8.11M | 0.2% | – | – | History |
| HOOKHOOKIPA Pharma Inc. | COM | 599,616 | $8.06M | 0.2% | – | – | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 1,025,000 | $7.67M | 0.2% | – | – | History |
| ACIUAC Immune SA | SHS | 1,000,000 | $7.61M | 0.2% | – | – | History |
| APLTApplied Therapeutics, Inc. | COM | 400,000 | $7.50M | 0.2% | – | – | History |
Options (13)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| CCitigroup Inc | Stock | – | $218.3M |
| GMGeneral Motors Co | COM | – | $201.1M |
| FFord Motor Co | Stock | – | $85.8M |
| INTCIntel Corp | Stock | – | $83.2M |
| BACBank of America Corp | Stock | – | $77.4M |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | – | $67.8M |
| BMYBristol Myers Squibb Co | Stock | – | $63.1M |
| AAAlcoa Corp | Stock | – | $48.7M |
| FCXFreeport-McMoran Inc | Stock | – | $32.9M |
| SLBSLB Limited | Stock | – | $27.2M |
| Kraneshares Trust500767306 | CSI CHI INTERNET | – | $15.3M |
| BMRNBiomarin Pharmaceutical Inc | COM | – | $11.3M |
| State Street Energy Select Sector SPDR ETF81369Y506 | ETF | – | $2.45M |